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Summary
Tight junctions (TJs) regulate the paracellular movement of ions, macromolecules and immune cells across epithelia. Zonula occludens
(ZO)-1 is a multi-domain polypeptide required for the assembly of TJs. MDCK II cells lacking ZO-1, and its homolog ZO-2, have three
distinct phenotypes: reduced localization of occludin and some claudins to the TJs, increased epithelial permeability, and expansion of
the apical actomyosin contractile array found at the apical junction complex (AJC). However, it is unclear exactly which ZO-1 binding
domains are required to coordinate these activities. We addressed this question by examining the ability of ZO-1 domain-deletion
transgenes to reverse the effects of ZO depletion. We found that the SH3 domain and the U5 motif are required to recruit ZO-1 to the
AJC and that localization is a prerequisite for normal TJ and cytoskeletal organization. The PDZ2 domain is not required for localization
of ZO-1 to the AJC, but is necessary to establish the characteristic continuous circumferential band of ZO-1, occludin and claudin-2.
PDZ2 is also required to establish normal permeability, but is not required for normal cytoskeletal organization. Finally, our results
demonstrate that PDZ1 is crucial for the normal organization of both the TJ and the AJC cytoskeleton. Our results establish that ZO-1
acts as a true scaffolding protein and that the coordinated activity of multiple domains is required for normal TJ structure and function.
Key words: Tight junction, Zonula occludens, Paracellular permeability, Actin cytoskeleton, MAGUK, PDZ
Introduction
The tight junction (TJ) is a membrane-associated complex at the
apico-lateral margin of epithelial cells that regulates the paracellular
movement of ions, macromolecules and immune cells. The TJ barrier
is composed of three families of transmembrane proteins: claudins
(Furuse et al., 1998a), the junctional adhesion molecule (JAM)
proteins (Bazzoni et al., 2000), and the TJ-associated Marvel domain
proteins (TAMPs) occludin, tricellulin and Marvel D3 (Raleigh et al.,
2010). Claudins form adhesive contacts between cells that create a
charge and size-selective barrier (Colegio et al., 2002; Furuse et al.,
1998b; Morita et al., 1999; Van Itallie et al., 2008), while the TAMPs
and JAM proteins appear to play a role in stabilizing the TJ and
regulating epithelial permeability in response to pathogens and/or
physiological stimuli (Balda et al., 2000; Chen et al., 1997; Raleigh
et al., 2011; Van Itallie et al., 2010) (Ikenouchi et al., 2005) (Martı̀n-
Padura et al., 1998). These transmembrane barrier proteins are
associated with a cytosolic plaque of proteins that regulate their
assembly into a circumferential barrier and association with the
cortical cytoskeleton (reviewed by Furuse, 2010). The coordinated
interactions of these different components are critical for the assembly
and maintenance of an effective epithelial barrier.
The cytosolic proteins ZO-1 and ZO-2 are multi-domain
scaffolding proteins within the MAGUK family required for the
formation of the TJ. These two proteins are likely to play a
redundant role during TJ assembly. The depletion of either ZO-1 or
ZO-2 from epithelial cells leads to delayed formation of TJs and a
mild increase in permeability, whereas depletion of both ZO-1 and
ZO-2 disrupts the localization of the transmembrane proteins at the
tight junction and causes a dramatic alteration of TJ barrier
function (Hernandez et al., 2007; McNeil et al., 2006; Umeda et al.,
2006). The N-terminus of ZO proteins, like other MAGUKs,
contains a stereotypically conserved core of protein-binding
motifs, including three PDZ domains, an SH3 domain and a
GUK domain (reviewed by González-Mariscal et al., 2000). The
unique C-terminal domain contains an actin-binding region (ABR)
and interacts with many other cytoskeletal structural and
regulatory proteins (Fanning and Anderson, 2009; Fanning et al.,
1998; Wittchen et al., 1999). The transmembrane proteins claudin,
occludin and JAM all bind to distinct domains within the N-
terminal half of ZO-1 (Bazzoni et al., 2000; Fanning et al., 1998;
Furuse et al., 1994; Itoh et al., 1999; Riazuddin et al., 2006; Umeda
et al., 2006). ZO proteins also dimerize with each other through the
PDZ2 domain and dimerization of ZO-1 has been hypothesized to
be required for the organization of claudins into barrier-forming
strands (Fanning et al., 2007b; Utepbergenov et al., 2006; Wu et al.,
2007). Finally, ZO proteins regulate cytoskeletal organization
within the AJC (Fanning et al., 1998; Fanning et al., 2012; Van
Itallie et al., 2009). The N-terminal domains are sufficient to
recruit claudins and other TJ proteins to cell contacts at the apical/
lateral membrane, but whether this region is sufficient for
functional barrier assembly is still unknown (Ikenouchi et al.,



















The complex molecular structure of ZO-1 and the great diversity
in binding partners make dissection of the functional/mechanistic
role of this critical component challenging. It is unclear which
protein–protein interactions are necessary for epithelial-specific
functions, or how the activity of so many binding partners is
coordinated by ZO-1. The goal of this study, as the first step in a
long term analysis of ZO function, was to identify the ZO-1 binding
domains within the N-terminus that are necessary for TJ barrier
assembly and cytoskeletal regulation. We hypothesize that if ZO-1
is truly a scaffolding protein, multiple domains will be necessary
for ZO-1 to properly regulate TJ assembly, contractile array
formation and the establishment of an epithelial barrier. Our
laboratory has previously demonstrated that MDCK cells depleted
of ZO-1 and ZO-2 have three major phenotypes (Fanning et al.,
2012). First, the localization of some, but not all, TJ proteins is
significantly attenuated, yet there is little alteration in the
localization of the adherens junction proteins. Second, these cells
have a significantly expanded apical contractile array, highlighted
by an increase in actin and myosin accumulation at the adherens
junction. Finally, the depletion of both ZO-1 and ZO-2 leads to an
increase in the permeability of large solutes. To better understand
how ZO proteins coordinate TJ maintenance, we created
recombinant ZO-1 proteins lacking individual binding domains
and tested their ability to rescue the three phenotypes observed in
the ZO-depleted cells. Our results establish that cytoskeletal
organization and TJ structure and function are regulated by a
distinct, but overlapping, subset of conserved domains within ZO-1,
and suggest that complex interactions between different domains
and/or their binding partners is critical for normal barrier assembly.
Results
N-terminal half of ZO-1 is sufficient to rescue TJ protein
localization and cytoskeletal organization in ZO-depleted
cells
We previously reported that in ZO-depleted MDCK II cells the
localization of some, but not all, TJ transmembrane proteins to the
AJC is reduced. For example, accumulation of occludin, claudin-1
and claudin-2 at the AJC is significantly diminished relative to
control cells, while tricellulin, JAM, claudin-3 and -4 appear
normal. In addition, assembly of actomyosin filaments is greatly
increased relative to control cells (Fanning et al., 2012) (Fig. 1).
These defects are reversed by expression of a full length ZO-1
transgene in these cells (Fanning et al., 2012). To determine to
what extent the N-terminal binding domains are sufficient to
regulate TJ and cytoskeletal assembly at the AJC, we used a
tetracycline (Tet)-inducible system to express the N-terminal
portion of ZO-1 (cZNA) extending from the N-terminus through
the U6, or acidic domain (amino acids 1–887). As seen in Fig. 1A,
cZNA effectively localizes to the tight junction, restores claudin-2,
claudin-1 and occludin at the TJ (Fig. 1A; supplementary material
Fig. S1) and restores the normal distribution of F-actin and myosin
IIB at the AJC (Fig. 1B). These, and subsequent results, are
summarized in Table 1. cZNA localization does not exactly mimic
full length ZO-1 expression, nor does it restore the phenotypic,
wavy junctions of wild type MDCK cells or dKD cells expressing
full length ZO-1 (Fig. 1C) (Fanning et al., 2012), therein
confirming that the C-terminal region (aa 888–1746) has a role
in the orchestrating the typical architecture of the AJC in these
cells (Yu et al., 2010). However, we did not investigate these
differences further because they did not correlate with changes in
the permeability of MDCK cells (Fig. 1D).
The PDZ2, SH3 domains and U5 motif are necessary for the
normal localization of ZO-1
Next, we systematically deleted individual binding domains
within cZNA in order to determine which ones were responsible
for ZO-1 localization, TJ structure and organization of the AJC
Fig. 1. cZNA is sufficient to reverse most phenotypic alterations observed
in ZO-depleted MDCK cells. (A) MDCK and ZO-depleted MDCK cells
(Z2Z1 dKD) uninduced (U) and induced (I) to express the N-terminal half of
ZO-1 (cZNA) were fixed and stained with antibodies against ZO-1 (MDCK and
Z2Z1 dKD) or mCherry tag (cZNA), claudin-2, and occludin. (B) Cells were
stained with antibodies against myosin IIB and TRITC–phalloidin (F-actin).
(C) Cells expressing a ZNA construct or a full length ZO-1 (fl ZO-1) construct
were stained with antibodies against a myc tag to indicate the location of the
expressed protein and PAR3 to outline the AJC location. (D) Analysis of the
paracellular flux of 3.0 kDa fluorescein–dextran in Z2Z1 dKD cells uninduced
or induced to express ZNA or full length ZO-1 transgenes.
Immunofluorescence images are 1.3 mm maximum density projections of Z-
stacks taken through the apical-most aspect of the cells. Scale bars: 10 mm.


















cytoskeleton. Fig. 2A outlines each construct and the deletion
boundaries. All constructs contained an mCherry tag at the N-
terminus to distinguish the expressed protein from residual,
endogenous ZO-1. Western blot analysis confirmed that each
deletion transgene was expressed at levels comparable to cZNA,
and about a tenfold increase over levels of endogenous ZO-1 seen
in control cells (supplementary material Fig. S2). All cell lines
had comparable levels of occludin, myosin IIB and actin when
expression was induced or uninduced. Steady state levels of ZO-
3, which are notably reduced in ZO-depleted cells (Fanning et al.,
2012), were restored by the expression of all transgenes except
cZNADP2. This observation suggests that dimerization stabilizes
steady state levels of ZO-3. Claudin-2 expression was reduced in
some transgene-expressing cells (ZNA, cZNADP3 and
cZNADP2), as was the higher molecular weight species of
occludin sometimes associated with phosphorylation (Sakakibara
et al., 1997). Neither of these changes in steady state expression
pattern had an obvious correlation with changes in TJ
permeability or cytoskeletal organization, and was not pursued
further.
The deletion of individual domains had a surprisingly varied
effect on the localization of cZNA deletion constructs (Fig. 2B).
ZNA protein lacking the U5 (cZNADU5) or the SH3
(cZNADSH3) domains showed little or no localization to cell–
cell contacts. ZNA constructs lacking the GUK (cZNADGUK)
and PDZ3 (cZNADP3) domains localized to the tight junction in
a continuous circumferential pattern similar to cZNA. The ZNA
construct lacking the U6 domain (cZNADU6) localized to the
tight junction, but was also organized ectopically along the lateral
plasma membrane (Fig. 2C; supplementary material Fig. S3).
This ectopic localization pattern has been previously documented
by our lab (Fanning et al., 2007a). Interestingly, ZNA lacking the
PDZ2 domain (cZNADP2), which is responsible for dimerization
of ZO1 proteins (Utepbergenov et al., 2006; confirmed in
Fig. 3B), localized to the junction, but was unable to form a
continuous band around the cells. Instead, it was organized in a
distinct, discontinuous pattern along cell boundaries (Fig. 2B;
supplementary material Fig. S3). In the current study, we
confirmed that the cZNADP2 was unable to co-
immunoprecipitate with cZNA in transiently transfected HEK
cells (Fig. 3B). Furthermore, we demonstrated that the PDZ1,
SH3 and GUK domains were not required for cZNA
dimerization. These observations suggest that PDZ2-mediated
dimerization is required for a continuous circumferential
distribution of ZNA at the tight junction. Finally, ZNA lacking
the PDZ1 domain (cZNADP1) localized to the bi-cellular
junctions, but was occasionally absent from the tri-cellular
junctions. The observations summarized above suggest that the
localization of ZO-1 does not result from a simple binary
interaction between the SH3/U5 domains and a single binding
partner, but is instead modulated by the coordinated action of
several conserved protein-binding domains.
PDZ1 and PDZ2 regulate claudin-2 localization and
organization at the AJC
Our previous report established that the subcellular localization
of some, but not all, TJ proteins is altered in Z2Z1 dKD MDCK
Table 1. Effect of domain deletion on ZO-1 localization and function in MDCK cells




contractile array Claudin 2 localization Occludin localization Paracellular permeability
cZNADP1 Yes* No No No No
cZNADP2 Yes{ Yes No{ No No
cZNADP3 Yes Partial Yes Yes Yes
cZNADSH3 No No No No No
cZNADU5 No No No No No
cZNADGUK Yes Yes Yes Yes Yes
cZNADU6 Yes{ Yes Yes{ Yes{ Yes
cZNA Yes Yes Yes Yes Yes
*Excluded from tricellular junctions.
{Punctate, not a continuous band.
{Localization also visible on lateral membrane.
Fig. 2. The SH3, U5 and PDZ2 domains are all necessary for the
localization of ZO-1 into a continuous band at cell–cell contacts. Stable
Z2Z1 dKD cells were transfected with Tet-inducible cZNA rescue constructs
lacking individual binding domains. (A) Schematic diagram of rescue
constructs indicating the amino acid deletion boundaries. (B) Distribution of
mCherry-tagged transgenes in induced ZO-depleted MDCK cells. Images are
1.3 mm maximum density projections of Z-stacks taken through the apical-
most aspect of the cells. Scale bar: 10 mm.


















cells (Fanning et al., 2012). Decreased localization of occludin,
claudin-1 and claudin-2 to the AJC are particularly evident, and
correlate with changes in permeability, so we used these three
proteins as markers of TJ structural integrity. Claudins are well
characterized PDZ domain binding proteins (Itoh et al., 1999),
and using pull-down assays we confirmed previous observations
that PDZ1, but not PDZ2 or PDZ3, were required for interaction
of cZNA with a recombinant claudin-2 peptide (Fig. 3A).
Consistent with this observation, we found the ZNA construct
lacking the PDZ1 (cZNADP1) domain, which directly binds to
claudin, was unable to rescue localization of claudin-2 (Fig. 4) or
claudin-1 (supplementary material Fig. S1) to the AJC. In fact,
the small residual amount of claudin-2 normally observed in the
tight junction of Z2Z1 dKD cells was notably absent when
cZNADP1 is expressed in Z2Z1 dKD cells. These observations
indicate that direct binding of cZNA to claudin-2 is required for
localization to the AJC.
Expression of the cZNADP2 construct in ZO-depleted cells
was also able to promote the localization of claudin-2 to cell–cell
contacts (Fig. 4). However, this population of claudin-2 did not
form a smooth, continuous band around the cell boundaries;
instead it is distributed in a discontinuous pattern overlapping
with the recombinant cZNADP2 protein (supplementary material
Fig. S4). This observation suggests that PDZ-mediated
dimerization of ZO-1 is also required for a continuous
circumferential distribution of claudins at the tight junction.
Interestingly, cells expressing cZNADP3 effectively recruited
claudin-2 to the AJC, but claudin-1 localization was not rescued
by this construct. These observations reinforce that idea that
claudin localization to the AJC may not be regulated solely by
binary interactions with ZO proteins.
ZO-1 PDZ domains are required for occludin localization to
the AJC
The cytosolic tail of occludin binds to distinct structural elements
within the U5 motif and GUK domain in vitro (Fanning et al.,
1998; Furuse et al., 1994; Schmidt et al., 2004), but whether
direct interaction with either of these domains is necessary or
sufficient for incorporation of occludin into the AJC has not been
directly addressed. To address this issue, we first examined the
interaction of the cZNA transgenes with a GST occludin fusion
protein (Fig. 3C). cZNA binds robustly to a GST–occludin fusion
protein, whereas a fragment encoding the C-terminal 703 aa of
ZO-1 showed no detectable interaction. Interestingly, we found
that the presence of either the U5 motif or the GUK domain were
sufficient for occludin binding, whereas loss of both domains
(ZN 1–584) significantly reduced binding to GST–occludin. We
also detected a previously unappreciated role for PDZ domains in
the interaction of ZO-1 with occludin. Although deletion of
PDZ1 had no apparent effect on the interaction of cZNA with
GST–occludin, deletion of PDZ2 and PDZ3 both seriously
compromised this interaction.
The role of these different conserved domains in occludin
localization was similarly complex. Consistent with the binding
assays, the induction of cZNADP2 was unable to restore occludin
localization and the induction of cZNADP3, which demonstrated
attenuated binding, showed a much weaker rescue of occludin
localization than that seen with cZNA. Similarly, cZNADGUK,
which binds well to GST–occludin, was able to restore occludin
localization to the AJC (Fig. 5). However, induction of
cZNADP1, which interacts quite effectively with GST–occludin
in pull-down assays, was unable to rescue localization of
occludin. These observations, taken together, would suggest
Fig. 3. Conserved domains in ZNA make distinct, and sometimes overlapping, contributions to protein binding in vitro. (A) The PDZ2 domain is necessary
for ZO-1 dimerization. Human embryonic kidney (HEK) cells were co-transfected with YFP-tagged ZNA and the indicated myc-tagged deletion transgene.
Complexes were precipitated with an antibody against YFP, resolved by SDS-PAGE and analyzed by immunoblotting (IB) with antibodies against myc and YFP.
Note that deletion of the SH3 and GUK domains do not interfere with the co-precipitation of these transgenes with ZNA. (B) PDZ1 is required for Claudin-2
binding. HEK cells transfected with the indicated myc-tagged ZNA transgenes were lysed and mixed with MBP, MBP–claudin-2 or a claudin-2 fusion protein
lacking the last three amino acids (MBP–claudin-2D3). Bound proteins were analyzed by IB with anti-myc antisera, as above. (C) PDZ2, PDZ3 and U5/GUK are
required for interaction with occludin in vitro. ZNA deletion transgenes were incubated with GST or a GST–occludin (aa413–522) fusion protein. Bound proteins
were analyzed by IB with anti-myc antisera. Note that multiple domains are required for the interaction of ZNA with occludin. Input protein was 10% of the total.


















that the localization of occludin to the TJ is not a simple matter of
direct interactions with binding motifs in the U5 and GUK
domains. Instead, occludin interaction with ZNA and localization
to the TJ is dependent on the activity of other conserved domains,
such as PDZ1, PDZ2 and PDZ3.
Localization of ZO-1 to the AJC is required for TJ assembly
Induction of either the cZNADSH3 or the cZNADU5 constructs,
which are unable to localize to the membrane, was unable to
restore normal localization of claudin-2 or occludin, indicating
that ZO-1 localization to the AJC is required for normal
localization of these proteins. Expression of the cZNADU6
construct effectively promoted localization of both occludin and
claudin to cell–cell contacts. However, claudin and occludin were
not restricted to the AJC in these cells, but instead colocalized
with cZNADU6 in the lateral plasma membrane in the strand-like
arrays characteristic of this mutation (supplementary material
Fig. S2) (Fanning et al., 2007a). Taken together, our observations
suggest that the localization of TJ proteins like occludin and
claudin is regulated by a complex interaction between the
activities of multiple domains.
The PDZ1 domain is necessary for normal cytoskeletal
organization at the AJC
ZO-depleted MDCK cells have an expanded contractile array, as
demonstrated by the increased localization of both F-actin and
myosin IIB at the AJC (Fanning et al., 2012). Neither
cZNADSH3 nor cZNADU5, which do not localize to the
junctions, were able to restore a normal actin and myosin IIB
distribution, indicating that normal cytoskeletal assembly
requires localization of ZO-1 to the AJC (Fig. 6). Expression of
the cZNADP1 construct was also unable to restore a normal
contractile array within Z2Z1 dKD cells (Fig. 6). Most other
constructs tested were able to effectively restore the normal
distribution of F-actin and myosin IIB to the AJC (compare
Fig. 6 and Fig. 1B). However, cells expressing cZNADP3
displayed an intermediate phenotype in which the accumulation
of actin and myosin IIB within the AJC of these cells was
Fig. 4. The PDZ1, PDZ2 and SH3/U5 domains are
necessary for claudin-2 localization to cell–cell
contacts. Induced and uninduced Z2Z1dKD cells were
fixed and stained with antibodies against claudin-2. cZNA
images from Fig. 1 have been added for direct
comparison and line scans. Images are 1.3 mm maximum
density projections of Z-stacks taken through the apical-
most aspect of the cells. Line scans represent the intensity
of claudin staining at the cell–cell junction. Each line on
the graph represents an average of ten line scans taken
across the cell–cell junction of a different cell within the
image shown in the figure. The x-axis represents distance
along the 3 mm line scan and the y-axis represents
arbitrary intensity units (each mark520 units). Solid lines
show data from cells induced to express the transgene and
dotted lines are from uninduced cells. The axes for each
line scan graph are the same scale. Line scans of claudin-
2 in cZNADP2 cells were taken specifically at areas of the
junction where claudin was localized. Scale bar: 10 mm.
Fig. 5. The PDZ1, PDZ2 and SH3/U5 domains are
necessary for occludin localization to cell–cell
contacts. Z2Z1dKD cells with uninduced and induced
expression of rescue constructs were labeled for
occludin. cZNA images from Fig. 1 have been added
for direct comparison and line scans. Images are
1.3 mm maximum density projections of Z-stacks taken
through the apical-most portions of the cells. Line
scans represent the intensity of occludin staining at the
cell–cell junction. Each line on the graph represents an
average of five line scans, each taken across the cell–
cell junction of a different cell within the image shown
in the figure. Solid lines show data from cells induced
to express the transgene and dotted lines are from cells
not expressing the transgene. The x-axis represents
distance and the y-axis represents arbitrary intensity
units (each hash mark520 units). The axes for each
line scan graph are the same scale. Scale bar: 10 mm.


















attenuated compared to Z2Z1 cells, but not restored to a
completely normal distribution. Thus, PDZ1, and to a lesser
extent PDZ3, are involved in the normal regulation of
cytoskeletal structure within the AJC.
Ability of rescue constructs to establish a functional barrier
ZO proteins are necessary for normal cell permeability (Fanning
et al., 2012; Umeda et al., 2006; Van Itallie et al., 2009). Our
previous results demonstrated that cells lacking both ZO-1 and
ZO-2 maintain normal (or slightly increased) transepithelial
electrical resistance (TER), but have a significantly increased
permeability for larger molecules through the ‘leak pathway’
(Fanning et al., 2012). Re-expression of either ZO-1 or ZO-2 in
ZO-depleted cells reduced permeability to normal or near normal
levels (Fig. 1). Thus, to identify domains involved in the
regulation of the leak pathway, we examined the flux of 3 kDa
fluorescent dextrans across Z2Z1 dKD cell monolayers induced
to express the transgene. The results, shown in Fig. 7, are
presented as the fold increase over wild type MDCK cells culture
at the same time as the experiment cells.
Rescue constructs had one of three effects on the increased
permeability of ZO-depleted cells: they reduced, increased or had
no effect on permeability relative to uninduced cells (Fig. 7).
Expression of cZNA, cZNADGUK, cZNADU6 and cZNADP3
constructs in Z2Z1 dKD cells all reduced permeability to levels
characteristic of control MDCK cells. Induction of the cZNADP2
construct within Z2Z1 dKD cells had no effect on permeability;
these cells continued to maintain an increased permeability to
dextrans similar to uninduced cells. Finally, we found that cells
expressing cZNADP1, cZNADSH3 or cZNADU5 constructs
further increased epithelial permeability above levels seen in
uninduced Z2Z1 dKD cells. This effect was most dramatic in
cells expressing cZNADP1, where we saw a nearly tenfold
increase in permeability to 3 kDa dextran compared to uninduced
cells. Interestingly, cells expressing cZNADP1 and cZNADU5,
also had a significant decrease in TER compared to wild type
MDCK cells (supplementary material Fig. S5). Permeability of
larger dextrans was not assessed, because we found no significant
difference in the permeability of 40 kDa dextrans in ZO-depleted
cells relative to control cells (data not shown).
The U2 and U3 domains are not required for normal
ZO-1 function
The N-terminal portion of ZO-1 contains two additional large
unique regions, the U2 and U3 domains. ZNA constructs lacking
these domains (ZNADU2 and ZNADU3) localize to the AJC and
their expression within Z2Z1 cells restores epithelial permeability
to near normal levels (supplementary material Fig. S6). ZNADU2
and ZNADU3 expression also restores normal claudin, actin and
myosin localization to the AJC (supplementary material Figs S7,
S8). Thus, the U2 and U3 domains, which have no known binding
Fig. 6. The PDZ1, and to a lesser extent PDZ3, are required for normal
contractile array assembly. Z2Z1dKD cells expressing rescue constructs
were labeled for F-actin and myosin IIB. cZNA images from Fig. 1 are
included for comparison. Images are 1.3 mm maximum density projections of
Z-stacks taken through the apical-most portions of the cells. Scale bar: 10 mm.
Fig. 7. PDZ1, PDZ2 and SH3/U5 domains contribute to epithelial barrier
formation. Analysis of the paracellular flux of 3.0 kDa fluorescein–dextran
in ZO-depleted cells induced (I) and uninduced (U) to express rescue
constructs. The y-axis is the fold increase in dextran flux relative to control
MDCK cells cultured at the same time. All values are the mean 6 standard
deviation from quadruplicate readings and are representative of at least
three experiments.


















partners, are not necessary for normal ZO-1 function within
MDCK cells.
Discussion
Many factors contribute to the formation of epithelial TJs and the
regulation of epithelial permeability. Our results indicate that ZO-1
behaves as a multi-domain scaffold, and that coordinated activity of
multiple conserved protein-binding motifs is required for normal
organization and function of the steady state junction (Table 1).
This includes regions like SH3 and U5, which promote ZO-1
localization, the PDZ2 domain, which mediates dimerization, and
the PDZ1 domain, which binds directly to claudins. Our results
define a core set of functional activities that are critical to TJ
structure and maintenance of epithelial permeability.
ZO-1 must localize to the junction in order to rescue
permeability, tight junction assembly and regulation of
contractile array
This report reveals that localization of ZO-1 to the apical junction
complex is necessary for proper regulation of the tight junction
structure, permeability and organization of the Zonula adherens
(ZA) cytoskeleton. The larger SH3–U5–GUK region has been
previously implicated in junction localization (Fanning et al.,
2007a; Umeda et al., 2006) of ZO-1 and other MAGUKs (reviewed
by Fanning et al., 2007a). Our results indicate that the SH3 domain
and the U5 motif are required for localization of ZO-1 to cell–cell
contacts, but that the PDZ2 domain and the U6 motif appear to
‘fine-tune’ the distribution of ZO-1 within the lateral domain
(Fig. 2) (Fanning et al., 2007a). Our recent structural analysis of
ZO-1 suggests that the U5 domain is, in fact, a flexible loop
extending from the core SH3 domain (Lye et al., 2010). This report
would thus confirm that they are acting as a single functional unit.
The simplest model is that the SH3/U5 unit regulates TJ
localization through interactions with an as yet unidentified
‘anchor protein’. The U5 motif has no known binding partners
besides occludin, and occludin and its orthologs are not necessary
for TJ assembly (Raleigh et al., 2010; Saitou et al., 2000; Yu
et al., 2005). Similarly, although the SH3 domain of ZO-1 binds
to at least five different proteins, most of these proteins do not
appear necessary for tight junction assembly (Balda and Matter,
2000; Meyer et al., 2002; Tsapara et al., 2006). The one
exception is the AJ protein AF-6/afadin. The formation of both
AJ and TJ are compromised in AF6/afadin-depleted epithelia
(Ikeda et al., 1999; Komura et al., 2008; Lorger and Moelling,
2006; Ooshio et al., 2010; Zhadanov et al., 1999). However, AF-
6/afadin does not localize to the TJ in polarized cells, and co-
immunoprecipitation studies suggest that AF-6/afadin and ZO-1
only interact prior to TJ formation (Ooshio et al., 2010). Thus, we
believe any role for AF-6/afadin in TJ assembly is likely an
indirect effect of its role in adherens junctions. The identity of the
factor(s) that recruit ZO proteins to the AJC is still a matter of
great speculation.
The PDZ1 domain is necessary for claudin-1, -2 and
occludin localization and for formation of the TJ barrier
The seminal studies by Umeda et al. (Umeda et al., 2006)
demonstrated that ZO proteins are necessary for the assembly of
claudins and occludin into barrier strands and incorporation of
these strands into the apical circumferential complex. Unlike the
cells used by Umeda et al., our Z2Z1 dKD cells still incorporate
many TJ proteins, such as claudin 3, claudin 4, JAM and
tricellulin, into the AJC (Fanning et al., 2012). However, there
are several proteins that are not effectively incorporated into the
AJC in ZO-depleted MDCK cells, including claudin-1, claudin-2,
occludin and cingulin. We did not examine the distribution of
cingulin in cZNA rescue cells, because cingulin binds to the C-
terminus of ZO-1 and does not appear to play a major role in the
regulation of TJ structure or the epithelial barrier (Guillemot
et al., 2012).
Our examination of claudin-1, claudin-2 and occludin revealed
a complex interaction between these proteins and ZO-1. As
predicted, our results confirm that PDZ1 is required for direct
binding to claudin-2 in vitro (Itoh et al., 1999), and is necessary
for claudin-2 localization to cell–cell contacts. However, we
found that claudin-1 localization depended not only on PDZ1 for
AJC localization, but also required PDZ3. The reason for this is
currently unclear. Claudin-1 binds exclusively to PDZ1 in all of
the ZO proteins (Furuse et al., 1998a), so our observations
suggest that some PDZ3 ligand might stabilize claudin-1 at the
AJC. Taken together, our studies suggest that different claudins
are recruited to or stabilized at the AJC by diverse mechanisms.
Another surprising result of these studies was that the PDZ1
domain is not just required for the localization of claudin-2, but
also for the localization of occludin to the TJ. The occludin-
binding site has been previously mapped to structural elements
within the U5 motif and the GUK domain (Fanning et al., 1998;
Schmidt et al., 2004). Our results demonstrate that either domain
is sufficient for binding to ZO-1, but the absence of both
significantly attenuates the interactions between ZO-1 and
occludin. However, we found that cZNADP1, which associates
well with occludin in our binding assays, is unable to recruit
occludin to the AJC, indicating that direct binding of ZO-1 to
occludin is not sufficient to recruit occludin to junctions. A
previous study by Furuse et al. demonstrated that claudins could
markedly potentiate the assembly of occludin into cell–cell
contacts in L-cells transfected with claudins (Furuse et al.,
1998b). These observations lead us to hypothesize that the
maintenance of occludin at tight junctions is mediated by direct
or indirect interactions with organized claudin strands.
Our studies also strongly suggest that the PDZ1 domain is
necessary for the establishment of a physiological barrier.
Expression of cZNADP1 was not only unable to restore normal
localization of claudin-1 and -2 to the AJC, but it also further
enhanced the barrier disruption seen in ZO-depleted cells. This
included a 10-fold increase in flux through the leak pathway and a 5-
fold decrease in TER relative to the parental dKD cells. We
hypothesize that cZNADP1 acts as a dominant negative, and that
cZNADP1 displaces endogenous ZO-1 from junctions and
establishes an underlying scaffold that cannot directly interact
with barrier forming claudins. We interpret our observations to
suggest that direct interaction between ZO proteins and at least some
claudin polypeptides, like claudin-1 and -2, are required for steady
state structure and/or function of the barrier. While this seems like
the most likely hypothesis, we cannot rule out that the involvement
of PDZ1 in cytoskeletal assembly at the AJC (discussed below) may
also be involved in the regulation of the barrier. Future studies will
be directed at resolving this important issue.
The PDZ2 domain, a ZO dimerization motif, is required for
normal physiological barrier formation
The PDZ2 domain of ZO-1 is necessary for the dimerization of
ZO proteins (Fig. 3) and (Fanning et al., 2007b; Utepbergenov


















et al., 2006) and binding to connexins (Giepmans, 2004). While it
is theoretically possible that interaction of ZO-1 with connexins
promotes TJ barrier assembly, we believe it to be unlikely.
MDCK cells do not appear to have gap junctions or to be dye
coupled under normal conditions (Armitage and Juss, 2003; Jin
et al., 2004). Furthermore, the loss of TJ structure is not obvious
in most mouse connexin knockout models (Dobrowolski and
Willecke, 2009; Eckert and Fleming, 2008). Instead, our
interpretation is that dimerization mediated by PDZ2 is
necessary to recruit at least some TJ proteins, like ZO-1,
claudin-1, -2 and occludin, into a fully functional barrier. This is
based on our observation that cZNADP2 does not form a
continuous band around the apical portion of the cell, but is
instead co-distributed in a punctate pattern at the tight junction. A
similar punctate pattern is observed for claudin-1 and -2. Our
interpretation of these observations is that cZNADP2 polypeptide
is still able to recruit claudins into the AJC, but is unable to
‘cross-link’ these proteins into a continuous array.
Interestingly, the cZNADP2 polypeptide is also unable to bind
to occludin or restore its normal distribution at the TJ. The
implication of these observations is that dimerization of ZO-1 is
required for biochemical interaction with occludin, and that this
is somehow linked to occludin incorporation into the AJC. Unlike
claudin, the distribution of occludin in cells expressing
cZNADP2 is indistinguishable from that observed in uninduced
or ZO-depleted cells. These observations imply that occludin and
claudin-2 are stabilized at junctions by distinct mechanisms.
Direct interactions between ZO-1 and F-actin are not
required for barrier assembly or regulation of actomyosin
contractile arrays at the AJC
Tight junction structure and function are dependent on
cytoskeletal integrity, and can be acutely regulated by changes
in cytoskeletal dynamics (Shen and Turner, 2005). ZO-1 binds
directly to F-actin through a well-defined ABR region within the
C-terminus (Fanning et al., 1998; Itoh et al., 1997; Wittchen et al.,
1999) and it has been proposed that this direct interaction
transduces cytoskeletal signals that regulate the assembly and
function of the TJ barrier (Shen et al., 2006; Van Itallie et al.,
2009; Yu et al., 2010). In one notable example, Yu et al.
demonstrated that the ABR was required for the MLCK-
dependent changes in TJ dynamics and paracellular
permeability to ions in CACO2 cells (Yu et al., 2010). Tight
junctions also show acute changes in structure and function in
response to physiological and pathological stimuli that are
dependent on the cytoskeleton (reviewed by Cunningham and
Turner, 2012). Our results suggest that the mechanistic aspects of
cytoskeletal regulation within the AJC are quite complex. We
have confirmed the previous observation (Ikenouchi et al., 2007)
that the ZO-1 ABR is not required to recruit TJ proteins to the
apical junction complex. Furthermore, we demonstrate for the
first time that the ABR, and presumably direct interaction with F-
actin, is not required for maintenance of steady state barrier to
solutes (also known as the leak pathway) in MDCK cells.
Whether the ABR or other C-terminal binding domains are
required for acute barrier response to physiological stimuli,
particularly those that activate MLCK, will be the subject of
future studies.
We found that the ABR is also not required for the normal
regulation of contractile actomyosin arrays at the AJC. These
arrays, normally associated with the adherens junction, are
required for morphogenetic changes in cell shape that drive tissue
formation. However, we note that the change in junction
topology in Z2Z1 dKD cells from a relaxed/wavy configuration
to a straight configuration is not rescued by cZNA. These
observations have two important implications. First, they confirm
that the steady state architecture of the AJC is controlled by
elements within the C-terminus of ZO-1. One prediction, given
previous results (Yu et al., 2010; Shen et al., 2006), is that
regulation of junction topology involves direct interaction of the
ABR with F-actin. However, we note that similar changes in
junction topology in ZO-1 single KD cells are at least partially
rescued by a ZO-1transgene lacking only the ABR, suggesting C-
terminal domains outside of ABR may also be involved in
regulating junction topology (Van Itallie et al., 2009). Second,
our observations imply that the assembly of large contractile
arrays in Z2Z1 dKD cells is not directly responsible for the
change in junction profiles from wavy to straight. Thus, we
propose that changes in junction topology and the formation of
contractile arrays at the AJC are regulated by distinct cytoskeletal
mechanisms.
Much to our surprise, we found that it was PDZ1, and to a
lesser extent PDZ3, that are the critical domains for regulation of
contractile array formation at the cell junctions. There is no
known F-actin-binding domain within PDZ1 or PDZ3 of ZO-1
(Fanning et al., 1998; Itoh et al., 1997), therefore regulation of
the contractile array is likely through the binding of ZO-1 to
cytoskeletal regulatory proteins and/or other cytoskeletal
components. For example, PDZ1 is known to bind to alpha-
actinin 4 and ARVCF (Chen et al., 2006; Kausalya et al., 2004).
Future studies will address the role of PDZ1 ligands in regulating
cytoskeletal structure.
Closing remarks
Our results suggest that PDZ1 interactions, ZO protein
dimerization and localization to the apical junctional complex
are critical elements of ZO-protein-mediated TJ organization.
They also point to a previously unappreciated complexity in how
different proteins are recruited and stabilized at junctions. In
three examples discussed here, ZO-1-dependent localization and
binding appears to be mediated by interactions between multiple
domains and/or their binding partners. This observation suggests
several intriguing possibilities. For example, it suggests that the
interaction between different ZO protein ligands may stabilize
their distribution at the tight junction, or that steric and allosteric
regulation plays a role in ZO protein scaffolding. This study also
highlights the importance of identifying the factor(s) that bind to
the SH3/U5 motifs and recruit ZO proteins to the AJC.
Understanding which proteins are necessary to assemble and
maintain a functioning TJ and elucidating how these proteins are
regulated is critical for the development of therapeutic
approaches for disorders associated with aberrant permeability.
Materials and Methods
Cell lines and expression vectors
MDCK Tet-Off cells (clone T23; Clontech, Mountainview, CA) were maintained
at 37 C̊ and 5% CO2 in standard growth medium: DMEM (high glucose,
Mediatech, Manassas, VA) medium supplemented with 10% tetracycline-free fetal
bovine serum (FBS) (Atlas Biologicals, Fort Collins, CO), penicillin, and
streptomycin. Cells for immunocytochemistry and permeability assays were
maintained on 12 mm diameter Transwell filter inserts with a 0.4 mm pore size
(Corning, Corning, NY). Cells were maintained for 7 days with fresh media
changes every 2–3 days.


















The Z2Z1 dKD cells were constructed as previously described by Fanning et al.
(Fanning et al., 2012). C-myc-tagged ZO-1 transgenes lacking the PDZ2, PDZ3,
SH3, GUK, and U5 regions, or encoding the ZNA and ZNADU6 transgenes, were
previously created in the pCB6 expression vector (Fanning et al., 2007a). The ZNA
and ZNADU6 constructs were transferred from pCB6 vectors to pTRE vectors. To
create the ZNADP2, ZNADP3 and ZNADSH3 constructs, EcoRI–NheI fragments
encompassing the deletion were subcloned from the pCB6 vectors and inserted
into the corresponding EcoRI–NheI site within the pTRE ZNA vector. The
ZNADU5 construct was created by transferring a StuI fragment from pCB6
ZO1DU5 into the corresponding StuI site in pTRE ZNA. To create the ZNADGUK
construct, an AccI fragment from the pCB6 ZO1DGUK was inserted into the
corresponding AccI site in the pTRE ZNA. To construct ZNADP1, PCR was used
to amplify an AgeI–NheI fragment encoding amino acids (aa) 110–582 (primer
sequences: 59-GCACCGGTAAAGTTCAAATACCAGTAAGTCG-39 and 59-
CTGCGAAGACCTCTGAATCT-39). Site-directed mutagenesis was then used to
insert an Age I site at aa16 in pTRE ZNA (primer sequence: 59-
CACAGCAATGGAGGAAACCGGTATATGGGAACAACATACA-39), and the
PCR fragment encoding aa 110–582 was subcloned into the corresponding AgeI–
NheI site of this modified pTRE ZNA. To insert an mCherry tag and EcoRI site
was inserted in the 59 untranslated region of each pTRE construct using site-
directed mutagenesis, and an EcoRI–NotI fragment encoding mCherry was
subcloned into the EcoRI–NotI sites of the appropriate pTRE vector. To create
pTRE ZNADU2, we synthesized a gene fragment (GeneArt/Life Technologies)
encompassing an 847 bp EcoRI–BspEI fragment of human ZO-1 encoding aa 1–
339, absent sequence encoding aa 123–185. This fragment was subcloned into the
EcoRI–BspEI sites of pTRE ZNA. Similarly, to create pTRE ZNADU3, we
synthesized a gene fragment encompassing a 940 bp EcoRI–XbaI fragment of ZO-
1 encoding aa 1–450, absent sequences encoding aa 277–419. This fragment was
subcloned into the EcoRI–XbaI sites of pTRE ZNA.
The resulting pTRE vectors were co-transfected with a pTK-hyg plasmid into
Z2Z1 dKD cells. Stable clones were selected in 200 mg/ml hygromycin B (Sigma-
Aldrich). To inhibit transgene expression, cell lines were maintained in the
standard growth medium supplemented with 15 ml/l doxycycline. Transgene
expression was induced by maintaining cells in the standard growth media.
Immunocytochemistry
Filter inserts were processed as previously described by Fanning et al. (Fanning
et al., 2012). All inserts were fixed for 30 minutes in ice-cold ethanol. Primary
antibodies were used as follows: claudin-2 (Invitrogen; 1:100), occludin (Hycult
Plymouth Meeting, PA; 1:100), myosin IIB (Covance, Emeryville, CA; 1:250),
ZO-1 (R40.76; (Anderson et al., 1988); 1:25) and mCherry (Clontech; 1:500). The
appropriate species-specific affinity-purified Cy2-, Cy3-, or Cy5-conjugated
secondary antibodies were purchased from Jackson Immunoresearch and used at
a dilution of 1:100. F-actin was labeled using tetramethylrhodamine isothiocyanate
(TRITC)–phalloidin (Sigma Aldrich; 1:500). Samples were imaged on a Zeiss
LSM710 confocal microscope using a 606PlanApo lens. Photomultiplier settings
in each channel were identical for control, Z2Z1 dKD, and rescue construct cells
(both induced and uninduced conditions). Image stacks were acquired through the
1.33 mm apical-most portion of the cell with a step size of 0.33 mm. All volumes
were processed in the ZEN image browser (Zeiss, Thornwood, NY) and are
presented as maximum-density projections. At least two clones for each rescue
transgene were analyzed and a representative image was provided for the figures.
To examine cZNADP2 localization, transgene expression was attenuated by
adding low levels of doxycycline to the culture media. This improved the signal to
noise ratio for the tagged transgenes, but had little effect on the overall distribution
of the transgene at cell–cell contacts.
Western blots
Western blots were performed as previously described by Fanning et al. (Fanning
et al., 2012). Lysates were collected from 7-day cell cultures grown on filter
inserts. Primary antibodies were used as follows: ZO-1 (R40.76; (Anderson et al.,
1988); 1:2000), mCherry, (Clontech; 1:1000), claudin-2 (Invitrogen; 1:100),
occludin (Hycult; 1:500), actin (Millipore; 1:1000), myosin IIB (Covance; 1:1000)
and GAPDH (Sigma-Aldrich; 1:2000). The appropriate species-specific secondary
antibodies coupled to IRDyes (Rockland, Gilbertsville, MD) were used at
1:10,000. Western blots were imaged with the Odyssey infrared imaging system
(LI-COR Biosciences, Lincoln, NE).
Epithelial permeability
For both TER and FITC–dextran flux assays cells were plated at subconfluent
density and cultured for 7 days on 6.5 mm filter inserts with a 0.4 mm pore size
(Corning, Corning, NY). All measurements were performed in quadruplicate. Each
experiment was performed a minimum of three times; one representative
experiment is shown in the provided figures. TER was measured using an
EVOM volt–ohm meter (World Precision Instruments, Sarasota, FL). FLUX
assays were performed as follows. Cells were rinsed twice with Hank’s buffered
saline solution with calcium (HBSS+) (Mediatech, Manassas, VA) and then
incubated with fresh HBSS+ (200 ml on top of insert and 800 ml below the insert)
for 30 minutes at standard culture conditions. The apical chamber was then
replaced with 75 ml of a 0.3 mg/ml solution of 3 kDa fluorescein–dextran in
HBSS+ and placed in a receiving chamber containing 600 ml of fresh HBSS+. After
an initial 2 hours incubation, which allows cells to stabilize, the inserts were
removed and transferred to a new receiving chamber containing 600 ml HBSS+ and
incubated for an additional 2 hours. Flux was assayed by measuring the
concentration of FITC–dextran present in the basal chamber after the second 2-
hour incubation period using a Synergy HT plate reader (BioTek, Winooski, VT).
Co-immunoprecipitation assays
Human embryonic kidney (HEK) 293 Tet-Off cells were transfected with YFP-
tagged ZNA and a myc-tagged deletion transgene using Fugene HD according to
the manufacturer’s suggestions (Promega, Madison, WI). After 2 days, cells were
lysed on ice in immunoprecipitation (IP) buffer (20 mM TrisCl, 150 mM NaCl,
1% Triton X-100, 0.5% sodium deoxycholate and 0.1% SDS; pH 7.5)
supplemented with protease inhibitors (Roche Diagnostics, Mannheim,
Germany) and clarified by centrifugation at 10,000 g. The supernatant was pre-
cleared with protein-G–Sepharose (GE Biosciences) for 2 hours, incubated
overnight at 4 C̊ with 3.0 mg of mouse anti-GFP serum (Life Technologies, Grand
Island, NY) and supplemented with 20 ml Protein G Sepharose for an additional
2 hours at 4 C̊. The beads were washed three times with IP buffer, resolved by
SDS-PAGE and analyzed by western blotting with anti-myc (clone 9B11; Cell
Signaling Technology, Beverly, MA) and anti-GFP (A6455; Invitrogen) sera.
Western blots were imaged on an Odyssey Imager (LICOR, Lincoln, NE).
Claudin-2 tail binding assay
Recombinant 66HIS-tagged maltose-binding protein (MBP), MBP claudin-2 tail,
and an identical claudin-2 construct lacking the last 3 amino acids (MBP–claudin-
2D3) were expressed in E. coli and purified on Nickel-Sepharose HP (GE
Healthcare, Piscataway, NJ) as previously described (Van Itallie and Anderson,
2004). The concentration of protein bound to beads was assessed by UV
spectroscopy and confirmed by SDS-PAGE and Coomassie Brilliant Blue staining.
Protein-conjugated beads were diluted with Sepharose CL-4B (GE Healthcare) to a
final concentration of 0.2 mg/ml resin. For pull-down assays HEK 293 Tet-Off cells
were transfected with myc-tagged ZNA transgenes as described above. After 2
days, cells were lysed on ice for 10 min in 1 ml lysis buffer (20 mM Hepes,
150 mM NaCl, 1% v/v NP-40, 20 mM imidazole, protease inhibitors; pH 7.4) and
clarified by ultracentrifugation at 100,000 g. The supernatants were pre-cleared
overnight with 50 ml of Ni-MBP resin, diluted 1:1 in HEK lysis buffer and
incubated with 25 ml of MBP claudin-2 tail or MBP claudin-2D3 resin for 2 hours
at 4 C̊. Beads were washed three times with lysis buffer and eluted in 200 ml of
400 mM imidazole (pH 7.4). Protein samples were resolved by SDS-PAGE,
transferred to nitrocellulose, and probed with antisera against myc epitope.
Westerns were imaged as detailed above.
GST–occludin binding assay
GST and human GST–occludin tail (aa 413–522) were expressed in E. coli as
previously describe (Fanning et al., 2007a). Cells were harvested by centrifugation
at 10,000 g, resuspended in 10.0 ml resuspension buffer (25 mM Tris-HCl,
150 mM NaCl, 1 mM EDTA; pH 7.2) and incubated with 1.0 mg/ml chicken
lysozyme for 30 min on ice (Sigma-Aldrich, St. Louis, MO). The bacterial lysate
was adjusted to 1.0% Triton X-100 and 250.0 U/ml Benzonase (Sigma-Aldrich),
incubated on ice an additional 10 minutes and clarified by centrifugation at 20,000
g for 30 minutes. The soluble bacterial lysate was incubated with 0.25 ml of
glutathione agarose (Sigma-Aldrich) for 1 hour at 4 C̊ with gentle mixing and
washed three times in resuspension buffer. HEK cells were transfected with myc-
tagged ZNA transgenes as described above and, after 2 days, lysed on ice in 1.0 ml
of occludin lysis buffer (20 mM Tris-Cl, 150 mM NaCl, 0.05% w/v SDS, 1%
Triton X-100, 1 mM EDTA, 1 mM DTT, protease inhibitors, pH 7.5)
supplemented with phosphatase inhibitors (Roche Diagnostics) and clarified by
ultracentrifugation at 100,000 g for 30 minutes at 4 C̊. 500 ml of clarified
supernatant was diluted with equal volume lysis buffer and pre-cleared with 40 mg
of GST-agarose slurry for 2 hours at 4 C̊. The cleared lysate was incubated with
40 mg of GST–occludin resin (,1.0 mM) overnight at 4 C̊. The resin was then
washed three times in occludin lysis buffer (w/o protease/phosphatase inhibitors)
and once in TrisCl/NaCl pH 8.0. Bound protein was eluted in 50 ml of elution
buffer (25 mM TrisCl, 10 mM reduced glutathione; pH 9.0). The eluted protein
was resolved by SDS-PAGE, transferred to nitrocellulose, and probed with
antiserum against the myc epitope.
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